Document Detail


Biological markers in haematological malignancies.
MedLine Citation:
PMID:  24966076     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Haematological malignancies comprise a wide spectrum of well-defined entities, and require a risk-adapted treatment. Beside the classical diagnostic tools, haematologists have routinely access to more and more biological markers, which provide different informations about diagnosis, prognosis and targetable status of each individual disease and permit to define a personalized risk-adapted therapeutic strategy. We aim to describe these different biological markers and to pinpoint their accurate role in daily practice.
Authors:
Richard Lemal; Olivier Tournilhac; Jacques-Olivier Bay
Related Documents :
3079246 - Immunoglobulin deposition in skin of patients with lupus erythematosus: clinical correl...
6392366 - Factitial cutaneous ulcers and nodules: the use of electron-probe microanalysis in diag...
23282156 - Transcallosal approach for third ventriculostomy and removal of midbrain cavernous malf...
25073956 - Finding sessile serrated adenomas: is it possible to identify them during conventional ...
7994876 - A voluminous paraovarian cyst. case report.
21480116 - Malignant melanoma associated with congenital melanocytic nevus and diagnosed with inte...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Bulletin du cancer     Volume:  101 Suppl 1     ISSN:  1769-6917     ISO Abbreviation:  Bull Cancer     Publication Date:  2014 Jun 
Date Detail:
Created Date:  2014-06-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0072416     Medline TA:  Bull Cancer     Country:  France    
Other Details:
Languages:  eng     Pagination:  7-11     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Long-term inflammatory response to liquid injectable silicone, cartilage, and silicone sheet.
Next Document:  Immunology and personalized medicine in oncology.